Ultralife Q3 sales $39.5M (+18.8% YoY); operating income $2.1M vs loss

ULTRALIFE CORP

2023-Q3 EPS reported $0.19 revenue$114,096,000

GAAP net income $1.3M ($0.08 diluted EPS) vs net loss of $0.2M a year ago.
Adjusted EPS $0.10 vs adjusted loss of $0.03 in Q3 2022.
Gross margin improved 460 bps to 24.8% on price realization and level-loaded production.
Government/defense sales up 48.1%; commercial sales up 5.6%.
Backlog $101.1M at quarter-end, with over $35M expected to ship in remaining 2023.

item 2.02 item 9.01

Key facts

Extracted from this filing and checked against the source text.

Earnings Releases SEC 8-K Item 2.02 confidence 0.95

ULTRALIFE CORP reported third quarter ended September 30, 2023 results: revenue $39.5 million, net income $1.3 million or $0.08 per diluted share, EPS $0.08 per diluted share.

Period: third quarter ended September 30, 2023
Revenue: $39.5 million
Net income: $1.3 million or $0.08 per diluted share
EPS: $0.08 per diluted share
Result: reported results

Exact text from the filing

– October 26, 2023 -- Ultralife Corporation (NASDAQ: ULBI) reported operating results for the third quarter ended September 30, 2023 with the following highlights: ● Sales of $39.5 million representing an 18.8% year-over-year increase ● Operating income of $2.1 million versus a loss of $0.6 million for the 2022 third quarter ● Adjusted EPS of $0.10 compared to a

View on SEC.gov

Browse all earnings releases →

ULTRALIFE CORP filing history →

Source: SEC EDGAR

accession 0001437749-23-029034

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.